LEYDIG, VOIT & MAYER, LTD.

LEYDIG, VOIT & MAYER, LTD. specializes in patent law and intellectual property strategy for federal research and development programs, with deep expertise in drafting, filing, and prosecuting patent applications across international jurisdictions. The firm provides targeted legal services for biomedical and scientific innovations, including provisional and non-provisional U.S. patent filings, national phase entries under the PCT in Europe and other jurisdictions, and strategic responses to patent office actions. Their work centers on securing intellectual property rights for federally funded inventions, particularly in life sciences, with demonstrated proficiency in navigating complex patent prosecution timelines and procedural requirements under U.S. and international patent law. Key differentiators include precision in technical claim drafting for emerging biotechnologies and seamless coordination with federal research labs to align patent strategy with innovation milestones. The contractor maintains a consistent, long-standing relationship with the Department of Health and Human Services, where they serve as primary legal counsel for patent activities across multiple operating divisions including NHLBI and NIDDK. Their engagements involve end-to-end patent lifecycle management for government-funded research, from invention disclosure through global filing, often under tight statutory deadlines. While the Department of Justice appears in their history, all recent work is concentrated within HHS, indicating a focused specialization in biomedical IP rather than broad litigation or regulatory defense. Operating under NAICS 541110, the firm is positioned as a niche legal provider within the federal science and technology ecosystem, serving agencies that manage large-scale R&D portfolios. Their market positioning is defined by technical legal acumen in patent law rather than general legal services, making them a preferred partner for scientific agencies requiring specialized IP counsel. The firm is structured as a 2L entity headquartered in Chicago, Illinois, with no public certifications on record. They maintain a focused geographic presence aligned with federal research hubs, serving as a trusted legal advisor to U.S. government science programs without reliance on small business or minority-owned designations.